148,660 members

Skip to content. | Skip to navigation


NICE recommends lung cancer treatment


Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.

NICE recommends lung cancer treatment

Thousands of people with non-small-cell lung cancer (NSCLC) will benefit from draft guidance published by NICE recommending osimertinib (also called Tagrisso and made by AstraZeneca) at two different places in the treatment pathway for locally advanced or metastatic epidermal growth factor receptor (EGFR)-positive NSCLC.